Some drugs, such as 5-nitrobenzoate-2CP, inhibit the podoplanin-CLEC-2 union, which causes the inhibition of tumor cell-induced platelet aggregation (TCIPA) and the consequent prevention of tumor metastasis without the risk of hemorrhage [124]. Here, PDPN is linked to neoplasm.